|
Generic:
|
|
Sofosbuvir, Velpatasvir
|
| |
|
Therapeutic Class:
|
|
Hepatitis C Antivirals
|
| |
|
Composition:
|
|
Each MyHep All tablet contains Sofosbuvir 400 mg and Velpatasvir 100 mg.
|
| |
|
Description:
|
|
MyHep All is a fixed-dose combination tablet containing sofosbuvir and velpatasvir for oral administration. Sofosbuvir is a nucleotide analog HCV NS5B polymerase inhibitor and velpatasvir is an NS5A inhibitor.
|
| |
|
Indications:
|
|
| MyHep All is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) infection. |
|
Dosage:
|
|
The recommended dosage of MyHep All is one tablet taken orally once daily with or without food.
|
| |
|
Presentation:
|
- MyHep All Tab is available in a pack of 28’s.
|
|
|
